NCT02107131View on ClinicalTrials.gov

Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 13, 2015

Primary Completion Date

May 15, 2017

Study Completion Date

May 15, 2017

Conditions
Diabetic Macular Edema
Interventions
DRUG

Intravitreal ranibizumab 0.3mg

Trial Locations (6)

93039

California Retina Consultants - Bakersfield, Bakersfield

93103

California Retina Consultants - Santa Barbara Office, Santa Barbara

93277

California Retina Consultants, Visalia

93454

California Retina Consultants, Oxnard

California Retina Consultants, Santa Maria

93551

California Retina Consultants, Palmdale

All Listed Sponsors
lead

California Retina Consultants

OTHER

NCT02107131 - Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab | Biotech Hunter | Biotech Hunter